Evidence map›Paper›PMID 23801310›Full record

ArticleMolecular neurobiology2013

Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells.

Dah-Yuu Lu, Bor-Ren Huang, Wei-Lan Yeh, Hsiao-Yun Lin, Shiang-Suo Huang, Yu-Shu Liu, Yueh-Hsiung Kuo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of paeonol on anti-neuroinflammatory responses in microglial cells.International journal of molecular sciences · 2015
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Regulatory effects of fisetin on microglial activation.Molecules (Basel, Switzerland) · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Dah-Yuu LuGraduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan, dahyuu@mail.cmu.edu.tw.
Bor-Ren Huang
Wei-Lan Yeh
Hsiao-Yun Lin
Shiang-Suo Huang
Yu-Shu Liu
Yueh-Hsiung Kuo
China Medical University · TWChanghua Christian Hospital · TWChung Shan Medical University · TWNational Chung Hsing University · TWTaipei Tzu Chi Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that inflammatory processes in the central nervous system that are mediated by microglial activation play important roles in several neurodegenerative disorders. Therefore, development of methods for microglial inhibition is considered an important strategy in the search for neuroprotective agents. Caffeic acid phenethyl ester (CAPE) is distributed wildly in nature, but rapid decomposition by esterase leads to its low bioavailability. In this study, we investigated the effects of KS370G, a novel caffeic acid phenylethyl amide, on microglial activation. KS370G significantly inhibited the release of nitric oxide (NO) and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Treatment with KS370G also induced heme oxygenase (HO)-1 and suppressors of cytokine signaling (SOCS)-3 expression in the microglia. Furthermore, the anti-inflammatory effects of KS370G were found to be regulated by phosphorylated adenosine monophosphate-activated protein kinase-α (AMPK-α) translocated to the nucleus. Moreover, KS370G showed significant anti-neuroinflammatory effects on microglial activation in vivo and on motor behavior as well. The protective effect of KS370G was weakened by an AMPK inhibitor Compound C. This study focuses on the importance of key molecular determinants of inflammatory homeostasis, AMPK, HO-1, and SOCS-3, and their possible involvement in anti-neuroinflammatory responses.

Indexed as

AMP-Activated Protein KinasesAnimalsCaffeic AcidsHeme Oxygenase-1InflammationInterferon-gammaLipopolysaccharidesMiceMicrogliaMotor ActivityNervous SystemNeuroprotective AgentsRatsRats, Sprague-DawleySignal TransductionSuppressor of Cytokine Signaling 3 ProteinAMP-Activated Protein KinasesCaffeic AcidsHeme Oxygenase-1Interferon-gammaKS370GLipopolysaccharidesNeuroprotective AgentsSocs3 protein, ratSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling Proteins

Identifiers

PMID23801310
OpenAlexW1977494214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.